The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
Issued on behalf of MindWalk Holdings Corp. Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that is where one Nasdaq-listed company has placed...
Issued on behalf of MindWalk Holdings Corp. Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that is where one Nasdaq-listed company has placed...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.